Galderma Laboratories, L.P., a global leader focused on medical solutions in skin health, announced that it has received U.S. Food and Drug Administration (FDA) approval for the use of Restylane Lyft®, a

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In